Equities

Thalys Medical Technology Group Corp

603716:SHH

Thalys Medical Technology Group Corp

Actions
Health CareMedical Equipment and Services
  • Price (CNY)8.21
  • Today's Change-0.91 / -9.98%
  • Shares traded39.85m
  • 1 Year change-29.83%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments264337478
Total Receivables, Net1,7002,0322,182
Total Inventory342421464
Prepaid expenses74103111
Other current assets, total15577.67
Total current assets2,3952,9513,242
Property, plant & equipment, net204234277
Goodwill, net116142155
Intangibles, net343031
Long term investments324383385
Note receivable - long term435062
Other long term assets------
Total assets3,3423,9594,294
LIABILITIES
Accounts payable746720565
Accrued expenses466155
Notes payable/short-term debt452796691
Current portion long-term debt/capital leases9.4067110
Other current liabilities, total142192316
Total current liabilities1,3951,8361,737
Total long term debt597559799
Total debt1,0581,4221,600
Deferred income tax13175.88
Minority interest10494181
Other liabilities, total22499.41
Total liabilities2,1312,5562,731
SHAREHOLDERS EQUITY
Common stock202204205
Additional paid-in capital820834854
Retained earnings (accumulated deficit)300457611
Treasury stock - common(176)(188)(201)
Unrealized gain (loss)(30)2.06(2.48)
Other equity, total959494
Total equity1,2111,4031,562
Total liabilities & shareholders' equity3,3423,9594,294
Total common shares outstanding202204205
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.